French agricultural group InVivo said on Monday it had finalised a capital increase for its animal health and nutrition division that will see investors led by private equity firm Eurazeo inject 215 million euros ($235.3 million). InVivo said last year that it planned a capital increase to contribute about half of some 500 million euros in new financing as it seeks to double sales at the division over the next 10 years from 1.3 billion euros last year. Eurazeo said last month it was in negotiations to enter InVivo NSA's capital and indicated last week it was looking at investing 114 million euros. In an invitation to a March 30 signing ceremony, InVivo named the other participants in the capital increase as CDC International Capital (FFC), part of state-owned bank CDC, Credit Agricole's Idia unit and grain sector investment fund Unigrains. March 23, 2015 at 02:54PM
via Lazahealth.org
No comments:
Post a Comment